MEDISERV: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDISERV
Largest movements
- Cash +€22,198
up €22,198 (+62.1%), from €35,730 to €57,928
mainly Net result for the year (+€20,649) and Trade debts (+€1,683)
- Reserves +€20,649
up €20,649 (+48.2%), from €42,806 to €63,454
of which Distributable reserves: +€20,649
- Trade debts +€1,683
up €1,683 (+29.9%), from €5,636 to €7,319
- Gross operating margin -€7,257
down €7,257 (-26.5%), from €27,420 to €20,163
- Financial income +€1,189
up €1,189 (+34.3%), from €3,467 to €4,656
- Taxes -€388
down €388 (-14.2%), from €2,727 to €2,339
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €116,091 | €138,922 | +€22,832 | +19.7% |
| Fixed assets | 21/28 | €1,557 | €1,396 | -€161 | -10.3% |
| Tangible fixed assets | 22/27 | €1,557 | €1,396 | -€161 | -10.3% |
| Furniture and vehicles | 24 | €1,557 | €1,396 | -€161 | -10.3% |
| Current assets | 29/58 | €114,534 | €137,526 | +€22,992 | +20.1% |
| Amounts receivable after more than one year | 29 | €62,262 | €62,262 | = | 0.0% |
| Other amounts receivable | 291 | €62,262 | €62,262 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €12,638 | €12,775 | +€136 | +1.1% |
| Trade receivables | 40 | €12,638 | €12,775 | +€136 | +1.1% |
| Cash at bank and in hand | 54/58 | €35,730 | €57,928 | +€22,198 | +62.1% |
| Deferred charges and accrued income | 490/1 | €3,904 | €4,562 | +€658 | +16.8% |
| Total equity and liabilities | 10/49 | €116,091 | €138,922 | +€22,832 | +19.7% |
| Equity | 10/15 | €104,779 | €125,428 | +€20,649 | +19.7% |
| Contributions | 10/11 | €61,973 | €61,973 | = | 0.0% |
| Capital | 10 | €61,973 | €61,973 | = | 0.0% |
| Issued capital | 100 | €61,973 | €61,973 | = | 0.0% |
| Reserves | 13 | €42,806 | €63,454 | +€20,649 | +48.2% |
| Non-distributable reserves | 130/1 | €6,197 | €6,197 | = | 0.0% |
| Legal reserve | 130 | €6,197 | €6,197 | = | 0.0% |
| Distributable reserves | 133 | €36,608 | €57,257 | +€20,649 | +56.4% |
| Amounts payable | 17/49 | €11,312 | €13,495 | +€2,183 | +19.3% |
| Amounts payable within one year | 42/48 | €11,312 | €13,495 | +€2,183 | +19.3% |
| Trade debts | 44 | €5,636 | €7,319 | +€1,683 | +29.9% |
| Suppliers | 440/4 | €5,636 | €7,319 | +€1,683 | +29.9% |
| Taxes, remuneration and social security | 45 | €5,676 | €6,176 | +€500 | +8.8% |
| Taxes | 450/3 | €5,676 | €6,176 | +€500 | +8.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €669 | €718 | +€50 | +7.5% |
| Other operating charges | 640/8 | €1,072 | €1,076 | +€4 | +0.4% |
| Gross operating margin | 9900 | €27,420 | €20,163 | -€7,257 | -26.5% |
| Operating profit (loss) | 9901 | €25,679 | €18,369 | -€7,311 | -28.5% |
| Financial income | 75/76B | €3,467 | €4,656 | +€1,189 | +34.3% |
| Recurring financial income | 75 | €3,467 | €4,656 | +€1,189 | +34.3% |
| Financial charges | 65/66B | €35 | €37 | +€1 | +4.1% |
| Recurring financial charges | 65 | €35 | €37 | +€1 | +4.1% |
| Profit (loss) for the period before taxes | 9903 | €29,111 | €22,988 | -€6,123 | -21.0% |
| Income taxes | 67/77 | €2,727 | €2,339 | -€388 | -14.2% |
| Profit (loss) for the period | 9904 | €26,384 | €20,649 | -€5,735 | -21.7% |
| Profit (loss) for the period to be appropriated | 9905 | €26,384 | €20,649 | -€5,735 | -21.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.